FORTE BIOSCIENCES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $24.16 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $29.89, a 305.56% increase year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $7.37, a 895.95% increase year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.74, a 27.45% decline year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.02, a 37.42% decline year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $8.57, a 49.35% decline from fiscal 2024.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $16.92, a 2069.23% increase from fiscal 2023.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.78, a 46.94% decline from fiscal 2022.
- FORTE BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $1.47, a 95.89% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.16 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $29.89 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | $8.57 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $7.75 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $7.40 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $7.37 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | $16.92 10-K · filed 2025-03-28 | |||
| 2024-09-30 | $16.92 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $0.74 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $0.74 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | $0.78 10-K · filed 2024-03-18 | |||
| 2023-09-30 | $0.86 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $1.01 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $1.02 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $1.47 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $1.49 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $1.49 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $1.63 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $35.78 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $35.78 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | $37.89 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $36.94 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | $19.43 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $21.64 10-Q · filed 2020-11-09 | $16.79 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $13.39 10-Q · filed 2020-08-10 |